Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways

Abstract

Competing endogenous RNAs (ceRNAs) are RNA transcripts which can communicate with each other by decreasing targeting concentration of micro-RNA (miRNA) with the derepression of other messenger RNAs (mRNAs) having the common miRNA response elements (MREs). Oncocers are ceRNAs taking crucial roles in oncogenic pathways processed in many types of cancer, and this study analyzes oncocer-mediated cross-talk by sponging microRNAs (miRNAs) in these pathways. While doing this, breast, liver, colon, prostate, gastric, lung, endometrium, thyroid and epithelial cancers and melanoma, rhabdomyosarcoma, glioblastoma, acute promyelocytic leukemia, retinoblastoma, and neuroblastoma were analyzed with respect to ceRNA-based carcinogenesis. This study defines, firstly, oncocers in the literature and contains all oncocer-related findings found up to now. Therefore, it will help to increase our comprehension about oncocer-mediated mechanisms. Via this study, a novel perspective would be produced to make clear cancer mechanisms and suggest novel approaches to regulate ceRNA networks via miRNA competition for cancer therapeutics. Graphical Abstract Multiple RNA transcripts have common MREs for the similar miRNA in their 3'-untranslated regions (3'-UTRs). Upregulation of ceRNAs rises the abundance of specific MREs and shifts the miRNA pool distribution, as a result, leading to the increased expression of target mRNA. The depot of genomic mutations and epigenetic alterations changing gene function and expression causes cancers. Herewith, genome-based somatic base-pair mutations, DNA copy number alterations, chromosomal translocation, also transcript fusions, alternative splicing are usually seen in cancer situations. Consequently, such cases causing changed UTR expression in transcripts influence the levels of MRE or present new MREs into the cells. Alterations in MREs of ceRNAs affect the capability of a specific mRNA transcript to attach or titrate miRNAs. As a result, the disturbed ceRNA network can lead to diseases and cancers. As a new term in RNA world, oncocers-the name for ceRNAs taking crucial roles in oncogenic pathways-are processed in many types of cancer, and oncocer-mediated cross-talk are analyzed by sponging miRNAs in these pathways.

Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1

“…Any disturbance of this system may trigger a series of pathological processes in different human diseases, including cancers [29]. XIST inhibited cell proliferation and mobility in osteosarcoma by interacting with miR-21-5p and upregulating programmed cell death 4 (PDCD4) expression [30].…”

Long Noncoding RNA HOTAIR Controls Cell Cycle by Functioning as a Competing Endogenous RNA in Esophageal Squamous Cell Carcinoma

“…In this case, lncRNAs may function as competing endogenous RNAs (ceRNAs), namely, miRNA sponges or antagomirs, to downregulate the expression and activities of miRNAs, thereby modulating the derepression of miRNA targets and imposing an additional level of posttranscriptional regulation. The ceRNA-miRNA-mRNA regulatory interactions maintain the overall activity and functional balance of gene networks in a cell, and any perturbation of this system may lead to pathological processes such as cancer [8]. Thus, the complex mechanism underlying ceRNAs in cells is a fresh perspective for researchers to explore the language of RNA molecules and gene expression networks in tumorigenesis.…”

WITHDRAWN: LncRNA NEAT1 regulates epithelial-mesenchymal transition of osteosarcoma by miR-186-5p as competing endogenous RNA

“…Recently, studies suggested that lncRNAs could function as a competing endogenous RNA and sponge miRNAs, thus regulating the expression of target mRNA [11]. For example, Jiao et al showed that lncRNA UCA1 enhanced cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer [12].…”